Edit |   |
---|---|
Antigenic Specificity | CD248, Human (Ontuxizumab biosimilar) |
Clone | Ontuxizumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD248 Recombinant Antibody. Ontuxizumab is a humanized rabbit monoclonal antibody designed for the treatment of cancer. It binds to endosialin (TEM1 or CD248). Phase I trials are complete and the drug was granted orphan drug status by the FDA for sarcoma. It is currently in phase II trials for melanoma, colorectal cancer, sarcoma, and lymphoma. This drug was developed by Morphotek and Ludwig Institute for Cancer Research. |
Immunogen | n/a |
Other Names | Anti-CD248 Recombinant Antibody, Research Grade Ontuxizumab, Anti-Human CD248 Recombinant Antibody, MORAb-004, Antibody Drug Analogues, Monoclonal Antibody, YR1332, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 946415-62-9 |
Catalog # | YR1332 |
Price | please inquire |
Order / More Info | CD248, Human (Ontuxizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |